<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03449615</url>
  </required_header>
  <id_info>
    <org_study_id>SEOQ-MEL001</org_study_id>
    <nct_id>NCT03449615</nct_id>
  </id_info>
  <brief_title>Validation of Ferromagnetic Tracer in Melanoma Sentinel Node</brief_title>
  <acronym>IMINEM</acronym>
  <official_title>Isotopic Versus Magnetic Intraoperative Node Evaluation in Cutaneous Malignant Melanoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sociedad Española de Oncología Quirúrgica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sysmex España</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sociedad Española de Oncología Quirúrgica</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has been designed to validate a non-radioactive method to identify the sentinel
      lymph node using a superparamagnetic iron-oxide (SPIO) tracer respect to the traditional
      isotopic method. Both methods are used in every included patient and each patient is its own
      control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Injection of the isotopic tracer in standard form and in the usual preoperative period
           (hours-day).

        -  Identical injection in three-four punctures of 2 mL of Sienna+ ® and local massage of
           5-10 minutes.

        -  Optional: colorant injection in standard form. Local massage of 5-10 minutes.

        -  After 20 minutes: transcutaneous measurement with SentiMag®

        -  Valuing territories (lymphoscintigraphy information?)

        -  Surgical identification measures:

             1. st with SentiMag®

             2. nd with gamma detection probe

        -  Ex vivo check and HRD record
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SN detection</measure>
    <time_frame>During surgery</time_frame>
    <description>Detection of potential sentinel nodes using both methods (isotopic and ferromagnetic tracers). Máximum register of isotopic and ferromagnetic measurement will be the main criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SN agreement</measure>
    <time_frame>During surgery</time_frame>
    <description>Agreement in isotopic and ferromagnetic sentinel node identification. Measurement criteria will be coincidence in the same node (or nodes).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">186</enrollment>
  <condition>Melanoma Stage</condition>
  <condition>Sentinel Lymph Node</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cutaneous malignant melanoma with indication for sentinel lymph node biopsy
        in staging.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (&gt;18 years of age),

          -  with diagnosis of cutaneous melanoma and

          -  in which SLNB is indicated as a staging method, and

          -  with cN0 result after clinical-echographic-cytohistological evaluation.

        Exclusion Criteria:

          -  Previous treatment with systemic therapy.

          -  Recent previous surgery (&lt;3 months) in the area susceptible of lymphatic drainage from
             the melanoma.

          -  Intolerance or hypersensitivity to iron or dextran compounds.

          -  Impossibility of use of radioisotope.

          -  Existence of pathology related to elevation of organic iron (hemosiderosis,
             hemochromatosis, iron deficiency anemia of metabolic or circulatory origin).

          -  Implantation of pacemakers or partially or totally metallic thoracic implants.

          -  Treatment with iron chelators (deferasirox, deferoxamine, ...).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Antonio Piñero Madrona, MD PhD</last_name>
    <email>pineromadrona@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clínico Universitario &quot;Virgen de la Arrixaca&quot;</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Piñero Madrona, MD PhD</last_name>
      <email>pineromadrona@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Antonio Piñero Madrona, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacobo Cabañas, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio R Rull, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Rodriguez, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesús Hernández Gil, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2018</study_first_submitted>
  <study_first_submitted_qc>February 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2018</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sociedad Española de Oncología Quirúrgica</investigator_affiliation>
    <investigator_full_name>Antonio Piñero-Madrona</investigator_full_name>
    <investigator_title>SEOQ Researcher</investigator_title>
  </responsible_party>
  <keyword>Cutaneous melanoma</keyword>
  <keyword>Sentinel node biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

